Embecta Corp (EMBC) Stock Price, Quote & News

Company Profile

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headqu...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 862 401 0000

Website: www.embecta.com

Address:

300 Kimball Drive, Suite 300, Parsippany, United States

LordWorld Jun. 14 at 10:36 AM

$EMBC https://www.linkedin.com/posts/rmhayes1_drugdelivery-combinationproducts-glp1-activity-7468298402523463681-5c9a?utm_source=share&utm_medium=member_ios&rcm=ACoAAF8uyZsBJ4KgRdzHO0a-goDvvWzFA3Mt4oA Also read this person's post and visit his Profile!!!!!!‼️‼️‼️ Also read this person's post and visit his Profile!!!!!!

0 · Reply

LordWorld Jun. 14 at 10:29 AM

$EMBC Read the post, like it, and share it. This is further proof that the stock price is currently temporary. I'm 99.9% sure that EMBC and Owen Mumford provide Dr. Reddy's with a full range of services, including logistics. The author of the LinkedIn post holds a position directly related to the selection of medical technology products and devices for Dr. Reddy's, and he specifically tagged Owen Mumford in the comments. https://www.reddit.com/r/TheRaceTo10Million/s/eXECBGFGfv LinkedIn:Piyush... Global Quality SME — M... mallikarjun patil ✅Aidaptus by Owen Mumford stands out as the most patient-friendly autoinjector. Its simple two-step operation —just remove the cap and press against the skin-makes it intuitive and easy to use, especially for first-time users or those with limited dexterity. Its ability to accommodate different fill volumes also supports the gradual dose escalation."

0 · Reply

Caribbe Jun. 12 at 9:09 PM

$EMBC That is one ugly 4 year chart.

1 · Reply

DDtrader444 Jun. 12 at 2:31 PM

$EMBC so oversold↗️↗️↗️

0 · Reply

TradingThyme Jun. 12 at 12:22 AM

$EMBC

1 · Reply

OrangeJoolius Jun. 11 at 3:40 PM

$EMBC Damn, covered too soon, should I short here or wait for a pop. Could retrace to all time low.

0 · Reply

yosiyosi Jun. 11 at 2:18 PM

$EMBC SELL SELL SELL !!!!!!!! I stopped writing here but I'm still convincing doctors to stop recommending this company's products - once their CEO blocks me I'll do everything I can to make this company go bankrupt - until I get back the $1500 I lost here.

1 · Reply

OrangeJoolius Jun. 10 at 2:18 PM

$EMBC Covered here, looking for the next pop to short.

1 · Reply

TradingThyme Jun. 10 at 1:42 PM

$EMBC Patience…..

0 · Reply

LordWorld Jun. 9 at 8:05 PM

$EMBC

1 · Reply

embecta to Participate in Investor Events

2026-05-18T12:09:46.000Z - 4 weeks ago

Embecta price target lowered to $3 from $11 at BofA

May 15, 2026, 9:00 AM EDT - 4 weeks ago

embecta Completes Acquisition of Owen Mumford Holdings Limited

May 13, 2026, 6:00 PM EDT - 4 weeks ago

Embecta Transcript: Bank of America Global Healthcare Conference 2026

May 8, 2026, 9:00 AM EDT - 5 weeks ago

embecta to Participate at the 2026 BofA Securities Global Health Care Conference

2026-05-07T06:57:11.000Z - 5 weeks ago

Embecta price target lowered to $5 from $12 at Mizuho

May 6, 2026, 9:41 AM EDT - 5 weeks ago

Embecta Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

May 5, 2026, 8:00 AM EDT - 5 weeks ago

Embecta Earnings Call Transcript: Q2 2026

May 5, 2026, 8:00 AM EDT - 5 weeks ago

Embecta Earnings release: Q2 2026

May 5, 2026, 8:00 AM EDT - 5 weeks ago

Embecta Slides: Q2 2026

May 5, 2026, 8:00 AM EDT - 5 weeks ago

Embecta Quarterly report: Q2 2026

2026-05-05T11:06:10.000Z - 5 weeks ago

Embecta lowers FY26 adjusted EPS view to $1.55-$1.75 from $2.80-$3.00

2026-05-05T10:48:58.000Z - 5 weeks ago

Embecta reports Q2 adjusted EPS 27c, consensus 42c

May 5, 2026, 6:30 AM EDT - 5 weeks ago

embecta Announces Quarterly Cash Dividend

May 5, 2026, 6:30 AM EDT - 5 weeks ago

Embecta Corp. Reports Second Quarter Fiscal 2026 Financial Results

2026-04-29T17:50:52.000Z - 6 weeks ago

Embecta management to meet virtually with BTIG

Apr 21, 2026, 5:00 PM EDT - 7 weeks ago

embecta to Report Fiscal Second Quarter Financial Results

2026-04-13T14:41:50.000Z - 2 months ago

Embecta price target lowered to $12 from $14 at Mizuho

2026-04-13T11:55:26.000Z - 2 months ago

Embecta price target lowered to $22 from $25 at BTIG

2026-03-19T10:46:35.000Z - 3 months ago

Embecta acquiring Owen Mumford Holdings

Mar 19, 2026, 6:30 AM EDT - 3 months ago

embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited

2026-02-11T21:21:38.000Z - 4 months ago

Embecta elects CEO Devdatt Kurdikar as chairman

Feb 11, 2026, 4:10 PM EST - 4 months ago

embecta names new Chairman of the Board and Lead Independent Director

Feb 5, 2026, 8:00 AM EST - 4 months ago

Embecta Earnings Call Transcript: Q1 2026

Feb 5, 2026, 8:00 AM EST - 4 months ago

Embecta Quarterly report: Q1 2026

Feb 5, 2026, 8:00 AM EST - 4 months ago

Embecta Earnings release: Q1 2026

Feb 5, 2026, 8:00 AM EST - 4 months ago

Embecta Slides: Q1 2026

2026-02-05T11:42:06.000Z - 4 months ago

Embecta reports Q1 adjusted EPS 71c, consensus 67c

2026-02-05T11:41:02.000Z - 4 months ago

Embecta backs FY26 adjusted EPS view $2.80-$3.00, consensus $2.89

Feb 5, 2026, 6:30 AM EST - 4 months ago

Embecta Corp. Reports First Quarter Fiscal 2026 Financial Results

Jan 23, 2026, 7:00 AM EST - 5 months ago

Embecta Proxy statement: Proxy Filing

Jan 22, 2026, 5:00 PM EST - 5 months ago

embecta to Report Fiscal First Quarter Financial Results

Jan 14, 2026, 5:15 PM EST - 5 months ago

Embecta Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 5:15 PM EST - 5 months ago

Embecta Slides: 44th Annual J.P. Morgan Healthcare Conference

Dec 18, 2025, 5:00 PM EST - 6 months ago

embecta to Participate at the J.P. Morgan 2026 Healthcare Conference

Dec 18, 2025, 7:00 AM EST - 6 months ago

Embecta Proxy statement: Proxy Filing

Dec 18, 2025, 7:00 AM EST - 6 months ago

Embecta Proxy statement: Proxy Filing

Nov 25, 2025, 8:00 AM EST - 7 months ago

Embecta Earnings Call Transcript: Q4 2025

Nov 25, 2025, 8:00 AM EST - 7 months ago

Embecta Annual report: Q4 2025

Nov 25, 2025, 8:00 AM EST - 7 months ago

Embecta Earnings release: Q4 2025

Nov 25, 2025, 8:00 AM EST - 7 months ago

Embecta Slides: Q4 2025

2025-11-25T11:35:52.000Z - 7 months ago

Embecta reports Q4 adjusted EPS 50c, consensus 46c

2025-11-25T11:35:41.000Z - 7 months ago

Embecta sees FY26 adjusted EPS $2.80-$3.00, consensus $2.95

Nov 25, 2025, 6:30 AM EST - 7 months ago

Embecta Corp. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2026 Financial Guidance

2025-11-17T22:05:09.000Z - 7 months ago

Embecta chairman David Melcher to retire, CEO Devdatt Kurdikar to succeed

Nov 17, 2025, 5:00 PM EST - 7 months ago

embecta announces changes to Board of Directors

Nov 14, 2025, 6:30 AM EST - 7 months ago

embecta Announces Major New Commitment to Direct Relief on World Diabetes Day

Nov 11, 2025, 5:00 PM EST - 7 months ago

embecta to Report Fiscal Fourth Quarter and Full Year 2025 Financial Results

2025-09-09T14:20:26.000Z - 9 months ago

Embecta management to meet with BTIG

Sep 4, 2025, 3:00 PM EDT - 10 months ago

Embecta Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

2025-08-08T18:45:13.000Z - 11 months ago

Embecta price target lowered to $11 from $18 at BofA

Aug 8, 2025, 8:00 AM EDT - 11 months ago

Embecta Earnings Call Transcript: Q3 2025

Aug 8, 2025, 8:00 AM EDT - 11 months ago

Embecta Quarterly report: Q3 2025

Aug 8, 2025, 8:00 AM EDT - 11 months ago

Embecta Earnings release: Q3 2025

Aug 8, 2025, 8:00 AM EDT - 11 months ago

Embecta Slides: Q3 2025

2025-08-08T10:41:58.000Z - 11 months ago

Embecta raises FY25 adjusted EPS view to $2.90-$2.95 from $2.70-$2.90

2025-08-08T10:35:32.000Z - 11 months ago

Embecta reports Q3 adjusted EPS $1.12 vs. 74c last year

Aug 8, 2025, 6:30 AM EDT - 11 months ago

Embecta Corp. Reports Third Quarter Fiscal 2025 Financial Results

Jul 24, 2025, 5:00 PM EDT - 11 months ago

embecta to Report Fiscal Third Quarter 2025 Financial Results

2025-07-16T11:42:06.000Z - 11 months ago

Embecta price target lowered to $12 from $13 at Mizuho

Jun 10, 2025, 1:20 PM EDT - 1 year ago

Embecta Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 5, 2025, 4:55 PM EDT - 1 year ago

Embecta Transcript: Jefferies Global Healthcare Conference 2025

May 22, 2025, 9:00 AM EDT - 1 year ago

Embecta Transcript: Investor Day 2025

May 22, 2025, 9:00 AM EDT - 1 year ago

Embecta Slides: FY 2025

May 22, 2025, 6:30 AM EDT - 1 year ago

embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day

May 9, 2025, 8:00 AM EDT - 1 year ago

Embecta Earnings Call Transcript: Q2 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Embecta Quarterly report: Q2 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Embecta Earnings release: Q2 2025

May 9, 2025, 8:00 AM EDT - 1 year ago

Embecta Slides: Q2 2025

May 9, 2025, 6:30 AM EDT - 1 year ago

Embecta Corp. Reports Second Quarter Fiscal 2025 Financial Results

Apr 28, 2025, 7:30 AM EDT - 1 year ago

Embecta to host Analyst and Investor Day on May 22, 2025

Apr 21, 2025, 5:00 PM EDT - 1 year ago

embecta to Report Fiscal Second Quarter 2025 Financial Results

Apr 1, 2025, 8:05 AM EDT - 1 year ago

Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations

Feb 18, 2025, 5:00 PM EST - 1 year ago

embecta to Participate at the J.P. Morgan Global Leveraged Finance Conference

Feb 6, 2025, 8:00 AM EST - 1 year ago

Embecta Earnings Call Transcript: Q1 2025

Feb 6, 2025, 8:00 AM EST - 1 year ago

Embecta Quarterly report: Q1 2025

Feb 6, 2025, 8:00 AM EST - 1 year ago

Embecta Earnings release: Q1 2025

Feb 6, 2025, 8:00 AM EST - 1 year ago

Embecta Slides: Q1 2025

Feb 6, 2025, 6:30 AM EST - 1 year ago

Embecta Corp. Reports First Quarter Fiscal 2025 Financial Results

Jan 23, 2025, 5:00 PM EST - 1 year ago

embecta to Report Fiscal First Quarter 2025 Financial Results

Jan 15, 2025, 10:30 AM EST - 1 year ago

Embecta Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 15, 2025, 10:30 AM EST - 1 year ago

Embecta Slides: FY 2025

Dec 19, 2024, 5:00 PM EST - 1 year ago

embecta to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 19, 2024, 7:00 AM EST - 1 year ago

Embecta Proxy statement: Proxy Filing

Dec 19, 2024, 7:00 AM EST - 1 year ago

Embecta Proxy statement: Proxy Filing

Nov 27, 2024, 4:38 PM EST - 1 year ago

Overlooked Stock: EMBC

Nov 26, 2024, 8:00 AM EST - 1 year ago

Embecta Earnings Call Transcript: Q4 2024

Nov 26, 2024, 8:00 AM EST - 1 year ago

Embecta Annual report: Q4 2024

Nov 26, 2024, 8:00 AM EST - 1 year ago

Embecta Earnings release: Q4 2024

Nov 26, 2024, 8:00 AM EST - 1 year ago

Embecta Slides: Q4 2024

Nov 26, 2024, 6:30 AM EST - 1 year ago

Embecta Corp. Reports Fiscal 2024 Fourth Quarter and Full Year Financial Results; Provides Initial Fiscal Year 2025 Financial Guidance; Discontinues Insulin Patch Pump Program; and Announces Restructuring to Streamline Operations and Reduce Costs

Nov 12, 2024, 5:31 PM EST - 1 year ago

UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

Nov 12, 2024, 5:00 PM EST - 1 year ago

embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

Nov 7, 2024, 6:30 AM EST - 1 year ago

embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell

Sep 16, 2024, 2:00 PM EDT - 1 year ago

Embecta Transcript: CL King's 22nd Annual Best Ideas Conference 2024

Sep 5, 2024, 2:35 PM EDT - 1 year ago

Embecta Transcript: Morgan Stanley 22nd Annual Global Healthcare Conference

Sep 3, 2024, 6:30 AM EDT - 1 year ago

embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes

Aug 9, 2024, 8:00 AM EDT - 2 years ago

Embecta Earnings Call Transcript: Q3 2024

Aug 9, 2024, 8:00 AM EDT - 2 years ago

Embecta Quarterly report: Q3 2024

Aug 9, 2024, 8:00 AM EDT - 2 years ago

Embecta Earnings release: Q3 2024

Aug 9, 2024, 8:00 AM EDT - 2 years ago

Embecta Slides: Q3 2024

Aug 9, 2024, 6:30 AM EDT - 2 years ago

Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results

Jul 29, 2024, 8:05 AM EDT - 2 years ago

Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company

Jul 18, 2024, 5:00 PM EDT - 2 years ago

embecta to Report Fiscal Third Quarter 2024 Financial Results

Jun 24, 2024, 6:30 AM EDT - 2 years ago

embecta-sponsored Abstracts Presented at American Diabetes Association's 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin Reservoir

Jun 20, 2024, 7:30 AM EDT - 2 years ago

Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors

May 17, 2024, 4:30 PM EDT - 2 years ago

Embecta (EMBC) CEO on Diabetes Treatment Market

May 16, 2024, 1:00 PM EDT - 2 years ago

Embecta Transcript: BofA Securities 2024 Health Care Conference

May 9, 2024, 8:00 AM EDT - 2 years ago

Embecta Earnings Call Transcript: Q2 2024

May 9, 2024, 8:00 AM EDT - 2 years ago

Embecta Quarterly report: Q2 2024

May 9, 2024, 8:00 AM EDT - 2 years ago

Embecta Earnings release: Q2 2024

May 9, 2024, 8:00 AM EDT - 2 years ago

Embecta Slides: Q2 2024

May 9, 2024, 6:30 AM EDT - 2 years ago

Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results

Apr 23, 2024, 5:00 PM EDT - 2 years ago

embecta to Report Fiscal Second Quarter 2024 Financial Results

Mar 6, 2024, 6:00 AM EST - 2 years ago

embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes

LordWorld Jun. 14 at 10:36 AM

0 · Reply

LordWorld Jun. 14 at 10:29 AM

0 · Reply

Caribbe Jun. 12 at 9:09 PM

$EMBC That is one ugly 4 year chart.

1 · Reply

DDtrader444 Jun. 12 at 2:31 PM

$EMBC so oversold↗️↗️↗️

0 · Reply

TradingThyme Jun. 12 at 12:22 AM

$EMBC

1 · Reply

OrangeJoolius Jun. 11 at 3:40 PM

$EMBC Damn, covered too soon, should I short here or wait for a pop. Could retrace to all time low.

0 · Reply

yosiyosi Jun. 11 at 2:18 PM

1 · Reply

OrangeJoolius Jun. 10 at 2:18 PM

$EMBC Covered here, looking for the next pop to short.

1 · Reply

TradingThyme Jun. 10 at 1:42 PM

$EMBC Patience…..

0 · Reply

LordWorld Jun. 9 at 8:05 PM

$EMBC

1 · Reply

LordWorld Jun. 9 at 2:04 PM

$EMBC https://www.reddit.com/r/Pennystock/s/y6BAdiDtki

0 · Reply

OrangeJoolius Jun. 4 at 4:27 PM

$EMBC LMAO. Short. Every. Pop. Easy money.

1 · Reply

LordWorld Jun. 4 at 2:13 PM

$EMBC

0 · Reply

DDtrader444 Jun. 4 at 10:13 AM

$EMBC 🤯↗️↗️↗️

0 · Reply

OrangeJoolius Jun. 3 at 6:59 PM

$EMBC Easy 5% short trade, thanks again bulls! Spike it up again for me please!

1 · Reply

OrangeJoolius Jun. 3 at 4:41 PM

$EMBC Down she goes as always, up on my latest short.

0 · Reply

LordWorld Jun. 3 at 8:09 AM

$EMBC Roth Anthony M. (Anthony M. Roth). His position: VP, Chief Accounting Officer (Vice President and Chief Accountant of Embecta). What exactly happened to the shares? Transaction date: June 1, 2026 (the document was signed and filed on June 2, 2026). Transaction type: The table shows the code "A" (Acquired), which means that the top manager received (purchased) shares. Quantity: 30,000 common shares (Common Stock).He chose shares over cash!!! This man is the chief accountant, and he has complete control over the company!!! And one more question: where did EMBC get the shares? A share buyback???✅

0 · Reply

LordWorld Jun. 2 at 8:01 PM

$EMBC

0 · Reply